TD Cowen lowered the firm’s price target on Biote (BTMD) to $2.50 from $3 and keeps a Buy rating on the shares. The firm said 4Q25 sales and& EBITDA beat but FY26 guide was below Street, reflecting the impact of voluntary recall, a step up in investment, and growth resuming in 2H26.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTMD: